AbbVie Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
AbbVie Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
  • AbbVie Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $1.56B, a 12.2% decline year-over-year.
  • AbbVie Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $5.12B, a 21.4% decline year-over-year.
  • AbbVie Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $4.86B, a 58.9% decline from 2022.
  • AbbVie Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $11.8B, a 2.55% increase from 2021.
  • AbbVie Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $11.5B, a 150% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.86B -$6.97B -58.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $11.8B +$294M +2.55% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $11.5B +$6.93B +150% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $4.62B -$3.27B -41.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $7.88B +$2.2B +38.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $5.69B +$378M +7.12% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $5.31B -$644M -10.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $5.95B +$809M +15.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $5.14B +$3.37B +190% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $1.77B Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.